Webinar: Pediatric Dyslipidemias: Screening, Diagnosis, and Management in the Primary Care Setting (recorded live)
Jan. 2022Important Notices
"Watch the webinar recorded live May 19, 2021, where Brenda Mendizábal, MD, MS, Director of Pediatric Preventive Cardiology, UPMC Children’s Hospital of Pittsburgh, addresses improving the management of pediatric dyslipidemias.
During this hourlong session, Dr. Mendizábal discusses identifying children at greatest risk for accelerated atherosclerosis, formulating a plan for providing care to children with dyslipidemias, and the role of the pediatric preventive cardiologist.
Register or log in to listen to the webinar.
You may earn continuing medical education credits (CME) for watching this webinar.*
*This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Provider is responsible for verifying CME eligibility."
During this hourlong session, Dr. Mendizábal discusses identifying children at greatest risk for accelerated atherosclerosis, formulating a plan for providing care to children with dyslipidemias, and the role of the pediatric preventive cardiologist.
Register or log in to listen to the webinar.
You may earn continuing medical education credits (CME) for watching this webinar.*
*This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Provider is responsible for verifying CME eligibility."
Recent Announcements
Watch for a chance to rate your experience with UPMC Health Plan
Watch for a chance to rate your experience with UPMC Health Plan. You may be randomly selected to participate in a 2026 Press Ganey provider satisfaction survey that will begin this month.Aug. 2026Important Notices
Voluntary nationwide recall: Cetirizine (Unique – July)
Unique Pharmaceutical Laboratories (A Div. of J. B. Chemicals & Pharmaceuticals Ltd.) is recalling four lots (GY825029, GY825030, GY825031, GY825032) of Cetirizine Hydrochloride Tablets USP 5 mg. Cetirizine is used for the relief of allergy symptoms, including itchy, red, watery eyes and itchy skin.Jul. 2026Pharmacy Updates
August 2026 UPMC for You and UPMC Community HealthChoices Formulary Updates
Effective Aug. 15, 2026, UPMC for You and UPMC Community HealthChoices are updating their formularies.Jul. 2026Pharmacy Updates